What is PT Darya-Varia Laboratoria Tbk Net Margin %?
PT Darya-Varia Laboratoria TbkISX:DVLA 73 Net Margin % is 9.30% as of Mar. 2026, which is 12% above its 10-year median of 8.33. GuruFocus rates ISX:DVLA with a GF Score™ of 73/100 and a GF Value™ of Rp1,840.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 953 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 52.05% on this metric.
The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Net Margin % or its related term are showing as below:
ISX:DVLA'
s Net Margin % Range Over the Past 10 Years
Min: 6.15 Med: 8.33 Max: 12.23
Current: 6.15
ISX:DVLA's Net Margin % is ranked better than 52.05% of 953
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs ISX:DVLA: 6.15
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PT Darya-Varia Laboratoria Tbk Net Margin % Related Terms
PT Darya-Varia Laboratoria Tbk Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:DVLA vs ZTS, UTHR, VTRS: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Net Margin % distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Net Margin % of 9.30% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is 12% above median its historical median of 8.33. Over the past decade, PT Darya-Varia Laboratoria Tbk's Net Margin % has ranged from 6.15 to 12.23. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #457 out of 953 companies in the Drug Manufacturers industry, placing it in the top 48%.
Is PT Darya-Varia Laboratoria Tbk's Net Margin % too high?
PT Darya-Varia Laboratoria Tbk's current Net Margin % of 9.30% is 12% above median its 10-year median of 8.33. Over the past 10 years, this metric has ranged from a low of 6.15 to a high of 12.23. The Drug Manufacturers industry median Net Margin % is 5.69. PT Darya-Varia Laboratoria Tbk's value of 9.30% is 63.4% above this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #457 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #457 out of 953 companies for Net Margin %. This puts PT Darya-Varia Laboratoria Tbk in the upper half of its industry. The industry median Net Margin % is 5.69. PT Darya-Varia Laboratoria Tbk's value of 9.30% is 63.4% above this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own Net Margin % has ranged from 6.15 to 12.23 over the past decade. While the company's 10-year median is 8.33 vs. the industry median of 5.69, PT Darya-Varia Laboratoria Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current Net Margin % of 9.30% is 63.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current Net Margin % is 9.30%, which is 12% above median its own 10-year median of 8.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,840.45, compared to a current price of Rp1,595.00 — trading 13.3% below its estimated fair value. The current Net Margin % is 9.30%, which is 12% above median its 10-year median of 8.33 and 63.4% above the Drug Manufacturers industry median of 5.69. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Net Margin % is 9.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued.
The current stock price of Rp1,595.00 is trading 13.3% below its estimated GF Value™ of Rp1,840.45.
GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.
Key valuation signals for ISX:DVLA:
Net Margin %: 9.30% (12% above median its 10-year median of 8.33)
GF Value™: Rp1,840.45 vs. price of Rp1,595.00 (13.3% below fair value)
Industry Position: 63.4% above the Drug Manufacturers median (#457 of 953)
No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Darya-Varia Laboratoria Tbk Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
73GF Score
Get the complete analysis for ISX:DVLA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DVLA has been successfully added to your 
